Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers

30 Jan 2019

Abstract excerpt

BACKGROUND: Endometrioid ovarian carcinoma and clear cell ovarian carcinoma are both classified as endometriosis-associated ovarian cancers (EAOCs). Despite the high rates of recurrence and mortality of EAOC, only a few prognostic biomarkers have been reported. Mitochondrial superoxide dismutase (SOD2) plays an important role in maintaining mitochondrial function through oxidative stress tolerance and contributes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Endometriosis Research and Treatment
Share to Glutathione Transferases and Polymorphisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30700285
DOI: 10.1186/s12957-019-1565-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancersPMID 30700285Read ↗

SOD2 Expression in Patients with Triple-Negative Breast Cancer is Associated with Tumor-infiltrating Lymphocytes and PrognosisSemantic proximity Read ↗

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathwaysSemantic proximity Read ↗

Risk of carcinoma in women with ovarian endometriomaSemantic proximity Read ↗

SLC11A2: a promising biomarker and therapeutic target in ovarian cancerSemantic proximity Read ↗

Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancerSemantic proximity Read ↗

Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancerSemantic proximity Read ↗

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinomaSemantic proximity Read ↗

Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancerSemantic proximity Read ↗

Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsetsSemantic proximity Read ↗

Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.Semantic proximity Read ↗

Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer.Semantic proximity Read ↗

Expression of Mitochondrial Regulators PGC1α and TFAM as Putative Markers of Subtype and Chemoresistance in Epithelial Ovarian CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.